Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Tyler Warbritton

Physician Assistant Huntingdon, TN Physician Assistant

NPI 1306498068 CMS profile 6562352

3493 Veterans Dr N Ste C, Huntingdon, TN 38344

Open in the dashboard

General payments

$2,649

159 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tyler Warbritton of Huntingdon, TN is reported in the CMS Open Payments database as having received $2,649 across 159 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $506 13
2024 General $68 4
2023 General $260 14
2022 General $886 60
2021 General $929 68

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tyler Warbritton
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Tyler Warbritton were reported at $506. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Tyler Warbritton Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $929 $132 $37–$438 $132
2022 $886 $155 $48–$522 $149
2023 $260 $167 $52–$557 $160
2024 $68 $178 $55–$600 $164
2025 $506 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Amgen Inc. $758 34 payments
  2. AbbVie, Inc. $586 45 payments
  3. Novo Nordisk Inc $279 17 payments
  4. Merck Sharp & Dohme Corporation $238 16 payments
  5. Lilly USA, LLC $214 14 payments
  6. AstraZeneca Pharmaceuticals LP $180 12 payments
  7. Otsuka America Pharmaceutical, Inc. $82 4 payments
  8. Lundbeck LLC $51 2 payments
  9. GlaxoSmithKline, LLC. $47 3 payments
  10. Boehringer Ingelheim Pharmaceuticals, Inc. $43 3 payments
  11. Other $171 9 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,649 159 payments
Products named General payments · program years 2021–2025
  1. EVENITY $618 21 payments
  2. VRAYLAR $338 29 payments
  3. STEGLATRO $224 15 payments
  4. Ozempic $222 14 payments
  5. RYBELSUS $205 13 payments
  6. TRULICITY $201 13 payments
  7. JARDIANCE $199 13 payments
  8. FARXIGA $180 12 payments
  9. Prolia $144 10 payments
  10. VERQUVO $142 9 payments
  11. Other $1,237 80 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 38 drugs

Part D claims

1,258

Median for Physician Assistant: 241

Drug cost

$14,199

Median for Physician Assistant: $4,110

Branded share of claims

21.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Janumet Xr Sitagliptin Phos/Metformin Hcl Brand 17 $4,728
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 70 $750
Duloxetine Hcl Generic 18 $676
Risperidone Generic 13 $641
Methylprednisolone Generic 84 $636
Amlodipine Besylate Generic 76 $477
Dicyclomine Hcl Generic 28 $433
Atorvastatin Calcium Generic 40 $382
Furosemide Generic 68 $362
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 68 $362

The 10 drugs with the highest cost, of 38 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 73 billing codes

Paid by Medicare

$154,657

Of which drugs: $89,171

Medicare patients

541

Average age 74

Services billed

25,433

357 women, 184 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 70%
Ischemic heart disease 30%
Diabetes 27%
Depression 26%
Osteoporosis 22%
COPD 21%
Heart failure 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, romosozumab-aqqg, 1 mg J3111 Office 15 4,831 $42,321
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg J7322 Office 35 1,750 $23,558
Injection, denosumab, 1 mg J0897 Office 15 900 $19,329
Injection, methylprednisolone acetate, 1 mg J1010 Office 147 16,323 $1,507
Injection, methylprednisolone acetate, 80 mg J1040 Office 41 44 $174
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 13 48 $4

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
EVENITY
  • Amgen Inc. $24
$24 — 4,831
Prolia
  • Amgen Inc. $24
$24 — 900
LEQVIO
  • Novartis Pharmaceuticals Corporation $19
$19 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

159 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record